TY  - THES
N2  - Current options for clinical metabolic activity (MA) imaging are limited. Positron Emission Tomography (PET) and 13C Magnetic Resonance Spectroscopic Imaging have relatively poor resolution and require radioactive or hyperpolarized tracers. We have developed a novel MRI-based metabolic activity diffusion imaging (MADI) approach that has no contrast agent injection and offers improved resolution compared to 18FDG-PET and 13C Magnetic Resonance Spectroscopic Imaging.
DO  - 10.6083/8049g576q
DO  - DOI
AB  - Current options for clinical metabolic activity (MA) imaging are limited. Positron Emission Tomography (PET) and 13C Magnetic Resonance Spectroscopic Imaging have relatively poor resolution and require radioactive or hyperpolarized tracers. We have developed a novel MRI-based metabolic activity diffusion imaging (MADI) approach that has no contrast agent injection and offers improved resolution compared to 18FDG-PET and 13C Magnetic Resonance Spectroscopic Imaging.
T1  - Metabolic activity diffusion imaging of rat brain glioma
DA  - 2023
AU  - Schlegel, Joshua
L1  - https://digitalcollections.ohsu.edu/record/10136/files/Schlegel.Joshua.2023.pdf
PB  - Oregon Health and Science University
PY  - 2023
ID  - 10136
L4  - https://digitalcollections.ohsu.edu/record/10136/files/Schlegel.Joshua.2023.pdf
KW  - Glioblastoma
KW  - Magnetic Resonance Imaging
KW  - Diagnostic Imaging
TI  - Metabolic activity diffusion imaging of rat brain glioma
Y1  - 2023
L2  - https://digitalcollections.ohsu.edu/record/10136/files/Schlegel.Joshua.2023.pdf
LK  - https://digitalcollections.ohsu.edu/record/10136/files/Schlegel.Joshua.2023.pdf
UR  - https://digitalcollections.ohsu.edu/record/10136/files/Schlegel.Joshua.2023.pdf
ER  -